Filter Results:
(3,421)
Show Results For
- All HBS Web
(3,421)
- People (9)
- News (721)
- Research (2,192)
- Events (38)
- Multimedia (28)
- Faculty Publications (1,298)
Show Results For
- All HBS Web
(3,421)
- People (9)
- News (721)
- Research (2,192)
- Events (38)
- Multimedia (28)
- Faculty Publications (1,298)
- 11 Apr 2017
- Blog Post
Why I Love My Job: Andrew Grochal on His Path to CarGurus
side of the business, working closely with each department across the entire company including sales, customer success, engineering and marketing. I lead a team of product managers and we all collaborate with engineering to prioritize ideas, develop those ideas into... View Details
Keywords: Technology
- January 2018
- Article
The Central and Unacknowledged Role of the U.S. Food and Drug Administration in the Design and Execution of Medical Device Pivotal Trials
By: Aaron V. Kaplan and Ariel D. Stern
The introduction of new medical devices has transformed cardiovascular care in recent decades. Devices, such as heart valves, pacemakers, stents, ventricular assist devices, and implantable defibrillators, have prolonged and improved the quality of life for millions of... View Details
Keywords: Health Testing and Trials; Business and Government Relations; Governing Rules, Regulations, and Reforms; Information Publishing; Medical Devices and Supplies Industry; United States
Kaplan, Aaron V., and Ariel D. Stern. "The Central and Unacknowledged Role of the U.S. Food and Drug Administration in the Design and Execution of Medical Device Pivotal Trials." JAMA Cardiology 3, no. 1 (January 2018): 5–6.
- 01 Mar 2011
- News
Entrepreneurs’ Fund
month. Said Rumennik, “The Minimum Viable Product Fund, or MVP Fund, alleviates the daunting financial barrier preventing students from building initial prototypes or test products, and encourages them to connect with like-minded peers.”... View Details
- 2008
- Chapter
Where is the Pharmacy to the World? Pharmaceutical Industry Location and International Regulatory Variation
By: Arthur A. Daemmrich
A consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a parallel development, patients and disease-based organizations have assumed greater... View Details
Keywords: Geographic Location; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Demand and Consumers; Pharmaceutical Industry; European Union; Germany; United States
Daemmrich, Arthur A. "Where is the Pharmacy to the World? Pharmaceutical Industry Location and International Regulatory Variation." Chap. 16 in Ways of Regulating: Therapeutic Agents between Plants, Shops, and Consulting Rooms. Vol. 363, edited by Jean Paul Gaudillière and Volker Hess, 271–290. Berlin, Germany: Max-Planck-Institut für Wissenschaftsgeschichte, 2008.
- Profile
Allie Corless
of playing to my strengths in shaping my career path. My experience at HBS among my peers and in the classroom was ideal for testing my weaknesses; post-graduation, my understanding of my strengths is helping me to decisively build my... View Details
- 01 Dec 2003
- News
Alumni Author: Thomas H. Fischgrund (MBA ’80)
score 1600? It is the top score. There are 138 questions on the test. You can miss one or two and still score 1600. What percentage of students score 1600? Each year, 2.3 million kids take the test and 650 score 1600 — that’s .03 percent!... View Details
- December 2006 (Revised August 2008)
- Case
Pervasis Therapeutics, Inc.
By: Robert F. Higgins and Virginia Fuller
In May 2005, Steve Bollinger was about to become president and chief operating officer of Pervasis Therapeutics, a small cell therapy start-up in Cambridge, Mass. If proven successful, Pervasis' product, Vascugel, could change the way vascular disease is treated and... View Details
Keywords: Business Startups; Venture Capital; Financial Strategy; Governing Rules, Regulations, and Reforms; Health Care and Treatment; Health Testing and Trials; Health Industry; Cambridge
Higgins, Robert F., and Virginia Fuller. "Pervasis Therapeutics, Inc." Harvard Business School Case 807-026, December 2006. (Revised August 2008.)
- Web
Research Resources | Baker Library
marketing materials, research and development documentation, test photographs, audiovisual materials, and annual reports. The material encompasses all aspects of the company’s history and has been broken down into the operational units of... View Details
- 17 Feb 2016
- Research & Ideas
Man vs. Machine: Which Makes Better Hires?
Some companies have begun relying more on computer-administered tests than human interviewers to find the best applicants. New research by Harvard Business School Assistant Professor Danielle Li and colleagues suggests that in this case,... View Details
- Portrait Project
Brett Odom
wondering where my life went. I pray every night that I can pass the "man in the mirror" test and succeed as husband, father, brother and friend. We all leave a trace in the world. I hope that if I keep the end in mind the rest... View Details
- Web
Accelerating Innovation | Social Enterprise | Harvard Business School
social investing. New Venture Competition 1_ujm0fcc5 It All Starts Here The Social Enterprise Track of the New Venture Competition provides an opportunity for students to explore social entrepreneurship and test ideas for social... View Details
- 23 Aug 2020
- News
In the UK, She Leads the Search for a COVID Vaccine
Kate Bingham (MBA 1991) Kate Bingham (MBA 1991) When she was asked to chair the UK’s Vaccine Taskforce back in May, Kate Bingham (MBA 1991) paused. Despite nearly three decades of experience as a life sciences investor with SV Health Investors, the enormity of leading... View Details
- 2010
- Chapter
From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance
By: Arthur A. Daemmrich
Adverse drug reactions pose distinct but potentially catastrophic risks to patients, physicians, pharmaceutical firms, and regulators. Between the early 1960s and the present, national systems were built to collect, standardize, and respond to individual reports of... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Testing and Trials; Business and Government Relations; Risk and Uncertainty; Safety; Pharmaceutical Industry; United States
Daemmrich, Arthur A. "From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance." Chap. 13 in The Fragmentation of U.S. Health Care: Causes and Solutions, edited by Einer Elhauge, 301–322. Oxford: Oxford University Press, 2010.
- 01 Oct 1997
- News
New Course for General Managers Broadens Managerial Scope and Builds Confidence
case studies used in the course came alive instantly, and the classroom visits by some of the cases' protagonists were enthusiastically received. Furthermore, the program's structure - two three-week units (one in March and one in May) - enables participants to... View Details
Keywords: Nancy O. Perry
- 27 May 2020
- Research & Ideas
What South Korea Teaches the World About Fighting COVID
whereas South Korea has 216 cases per million. "South Korea created a vast number of testing sites, which included not only big hospitals but local clinics and public health care facilities." What South Korea teaches us is that proactive... View Details
- February 2020
- Supplement
Theranos: Who Has Blood on Their Hands? (B)
By: Nien-he Hsieh, Christina R. Wing and John Masko
This supplemental case tracks the results of the Colman and Taubman-Dye class action suit against Theranos as well as Theranos’ other legal challenges and chronicles the final demise of the company in 2019. View Details
Keywords: Health Testing and Trials; Corporate Accountability; Organizational Culture; Misleading and Fraudulent Advertising; Crime and Corruption; Entrepreneurship; Lawsuits and Litigation; Business Exit or Shutdown; Medical Devices and Supplies Industry; California; United States
Hsieh, Nien-he, Christina R. Wing, and John Masko. "Theranos: Who Has Blood on Their Hands? (B)." Harvard Business School Supplement 320-091, February 2020.
- Web
Bearing engineer and his three dimensional graph - The Human Factor – Baker Library | Bloomberg Center, Historical Collections
science can point with precision to the specific lubricant which will give best possible service. Hitherto considered dry and abstract to the layman, such work saves years of hit and miss testing in the driving of many cars to arrive at... View Details
- Web
Making Kraft mayonnaise - The Human Factor – Baker Library | Bloomberg Center, Historical Collections
combines its skill with that of expert production men to assure unvarying highest quality. There is no guesswork in making Kraft Mayonnaise. Ingredients are purchased on laboratory specifications. They are blended with more than human accuracy. The finished product is... View Details
- December 2023 (Revised March 2024)
- Case
Manufacturing Moderna's Future
By: Satish Tadikonda and William Marks
In 2019, Moderna faced long odds of survival having failed to develop a successful clinical program out of the vast platform technology they had built around mRNA. Nearly overnight, the company skyrocketed to success with a vaccine for COVID-19, leading to an extremely... View Details
Keywords: Health Pandemics; Health Testing and Trials; Technological Innovation; Product Development; Production; Science-Based Business; Biotechnology Industry
Tadikonda, Satish, and William Marks. "Manufacturing Moderna's Future." Harvard Business School Case 824-076, December 2023. (Revised March 2024.)
- 19 May 2008
- Research & Ideas
Connecting School Ties and Stock Recommendations
there we hand-collected past education of analysts and matched these to past education of board members and senior officers of firms. These 1,800+ analysts represent those from the entire universe of analysts from 1990 to 2006 on which we could find education data. To... View Details